A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma
Clinical trial NCT04212013 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04212013
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-23
- Primary completion
- 2027-03-18
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.